These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 21294224)

  • 1. Desirability function combining metabolic stability and functionality of peptides.
    Van Dorpe S; Adriaens A; Vermeire S; Polis I; Peremans K; Spiegeleer BD
    J Pept Sci; 2011 May; 17(5):398-404. PubMed ID: 21294224
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analytical characterization and comparison of the blood-brain barrier permeability of eight opioid peptides.
    Van Dorpe S; Adriaens A; Polis I; Peremans K; Van Bocxlaer J; De Spiegeleer B
    Peptides; 2010 Jul; 31(7):1390-9. PubMed ID: 20347901
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glycodermorphins: opioid peptides with potent and prolonged analgesic activity and enhanced blood-brain barrier penetration.
    Negri L; Lattanzi R; Tabacco F; Scolaro B; Rocchi R
    Br J Pharmacol; 1998 Aug; 124(7):1516-22. PubMed ID: 9723966
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improved blood-brain barrier penetration and enhanced analgesia of an opioid peptide by glycosylation.
    Egleton RD; Mitchell SA; Huber JD; Palian MM; Polt R; Davis TP
    J Pharmacol Exp Ther; 2001 Dec; 299(3):967-72. PubMed ID: 11714884
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Brainpeps: the blood-brain barrier peptide database.
    Van Dorpe S; Bronselaer A; Nielandt J; Stalmans S; Wynendaele E; Audenaert K; Van De Wiele C; Burvenich C; Peremans K; Hsuchou H; De Tré G; De Spiegeleer B
    Brain Struct Funct; 2012 Jul; 217(3):687-718. PubMed ID: 22205159
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antinociceptive structure-activity studies with enkephalin-based opioid glycopeptides.
    Elmagbari NO; Egleton RD; Palian MM; Lowery JJ; Schmid WR; Davis P; Navratilova E; Dhanasekaran M; Keyari CM; Yamamura HI; Porreca F; Hruby VJ; Polt R; Bilsky EJ
    J Pharmacol Exp Ther; 2004 Oct; 311(1):290-7. PubMed ID: 15166257
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Brain to blood efflux transport of adenosine: blood-brain barrier studies in the rat.
    Isakovic AJ; Abbott NJ; Redzic ZB
    J Neurochem; 2004 Jul; 90(2):272-86. PubMed ID: 15228584
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Delivery of peptides to the brain: emphasis on therapeutic development.
    Banks WA
    Biopolymers; 2008; 90(5):589-94. PubMed ID: 18335425
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuropeptides and the blood-brain barrier.
    Pardridge WM; Frank HJ; Cornford EM; Braun LD; Crane PD; Oldendorf WH
    Adv Biochem Psychopharmacol; 1981; 28():321-8. PubMed ID: 7010940
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Opioid peptide drug development: transport of opioid chimeric peptides through the blood-brain barrier.
    Pardridge WM
    NIDA Res Monogr; 1992; 120():153-68. PubMed ID: 1501684
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of verapamil on the transport of peptides across the blood-brain barrier in rats: kinetic evidence for an apically polarized efflux mechanism.
    Chikhale EG; Burton PS; Borchardt RT
    J Pharmacol Exp Ther; 1995 Apr; 273(1):298-303. PubMed ID: 7714780
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New Angiopep-modified doxorubicin (ANG1007) and etoposide (ANG1009) chemotherapeutics with increased brain penetration.
    Ché C; Yang G; Thiot C; Lacoste MC; Currie JC; Demeule M; Régina A; Béliveau R; Castaigne JP
    J Med Chem; 2010 Apr; 53(7):2814-24. PubMed ID: 20210346
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Utilization of combined chemical modifications to enhance the blood-brain barrier permeability and pharmacological activity of endomorphin-1.
    Liu HM; Liu XF; Yao JL; Wang CL; Yu Y; Wang R
    J Pharmacol Exp Ther; 2006 Oct; 319(1):308-16. PubMed ID: 16803861
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Apical-to-basolateral transport of amyloid-β peptides through blood-brain barrier cells is mediated by the receptor for advanced glycation end-products and is restricted by P-glycoprotein.
    Candela P; Gosselet F; Saint-Pol J; Sevin E; Boucau MC; Boulanger E; Cecchelli R; Fenart L
    J Alzheimers Dis; 2010; 22(3):849-59. PubMed ID: 20858979
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo blood-brain barrier transport of oxycodone in the rat: indications for active influx and implications for pharmacokinetics/pharmacodynamics.
    Boström E; Simonsson US; Hammarlund-Udenaes M
    Drug Metab Dispos; 2006 Sep; 34(9):1624-31. PubMed ID: 16763013
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transport of nutrients and hormones through the blood-brain barrier.
    Pardridge WM
    Diabetologia; 1981 Mar; 20 Suppl():246-54. PubMed ID: 7014323
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Angiopep-2 modified PE-PEG based polymeric micelles for amphotericin B delivery targeted to the brain.
    Shao K; Huang R; Li J; Han L; Ye L; Lou J; Jiang C
    J Control Release; 2010 Oct; 147(1):118-26. PubMed ID: 20609375
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epilepsy and the blood-brain barrier.
    Cornford EM; Oldendorf WH
    Adv Neurol; 1986; 44():787-812. PubMed ID: 3085437
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Classification of Peptides According to their Blood-Brain Barrier Influx.
    Stalmans S; Gevaert B; Wynendaele E; Nielandt J; De Tre G; Peremans K; Burvenich C; De Spiegeleer B
    Protein Pept Lett; 2015; 22(9):768-75. PubMed ID: 26095378
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of blood-brain barrier permeability to PYY3-36 in the mouse.
    Nonaka N; Shioda S; Niehoff ML; Banks WA
    J Pharmacol Exp Ther; 2003 Sep; 306(3):948-53. PubMed ID: 12750431
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.